Gene · 4778
Papers2,142
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,142
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synergic Effect of Honey with Other Natural Agents in Developing Efficient Wound Dressings. | Antioxidants (Basel) | 2022 | 36670896 | PubTator, text mining | PubMed |
| The Role of Glucocorticoids in Breast Cancer Therapy. | Curr Oncol | 2022 | 36661673 | PubTator, text mining | PubMed |
| Acute Myeloid Leukemia Following Myeloproliferative Neoplasms: A Review of What We Know, What We Do Not Know, and Emerging Treatment Strategies. | J Hematol | 2022 | 36632576 | PubTator, text mining | PubMed |
| Impact on the Clinical Evolution of Patients with COVID-19 Pneumonia and the Participation of the NFE2L2/KEAP1 Polymorphisms in Regulating SARS-CoV-2 Infection. | Int J Mol Sci | 2022 | 36613859 | PubTator, text mining | PubMed |
| Impact of Molecular Biology in Diagnosis, Prognosis, and Therapeutic Management of BCR::ABL1-Negative Myeloproliferative Neoplasm. | Cells | 2022 | 36611899 | PubTator, text mining | PubMed |
| AUF-1 knockdown in mice undermines gut microbial butyrate-driven hypocholesterolemia through AUF-1-Dicer-1-mir-122 hierarchy. | Front Cell Infect Microbiol | 2022 | 36601302 | PubTator, text mining | PubMed |
| Bioinformatic Analysis of Genetic Factors from Human Blood Samples and Postmortem Brains in Parkinson's Disease. | Oxid Med Cell Longev | 2022 | 36593912 | PubTator, text mining | PubMed |
| Targeting TLR2/Rac1/cdc42/JNK Pathway to Reveal That Ruxolitinib Promotes Thrombocytopoiesis. | Int J Mol Sci | 2022 | 36555781 | PubTator, text mining | PubMed |
| Mitochondrial Dysfunction and Oxidative Stress in Hereditary Ectopic Calcification Diseases. | Int J Mol Sci | 2022 | 36499615 | PubTator, text mining | PubMed |
| The Role of Single-Nucleotide Polymorphisms in Cholangiocarcinoma: A Systematic Review. | Cancers (Basel) | 2022 | 36497451 | PubTator, text mining | PubMed |
The anterior gradient homologue 2 (AGR2) co-localises with the glucose-regulated protein 78 (GRP78) in cancer stem cells, and is critical for the survival and drug resistance of recurrent glioblastoma: in situ and in vitro analyses. | Cancer Cell Int | 2022 | 36482387 | PubTator, text mining | PubMed |
| Role of NRF2 in Colorectal Cancer Prevention and Treatment. | Technol Cancer Res Treat | 2022 | 36476179 | PubTator, text mining | PubMed |
| Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patients. | Sci Rep | 2022 | 36456645 | PubTator, text mining | PubMed |
| Structural basis of transcription regulation by CNC family transcription factor, Nrf2. | Nucleic Acids Res | 2022 | 36454022 | PubTator, text mining | PubMed |
| Natural products in cosmetics. | Nat Prod Bioprospect | 2022 | 36437391 | PubTator, text mining | PubMed |
Isothiocyanate-Rich Extracts from Cauliflower (Brassica oleracea Var. Botrytis) and Radish (Raphanus sativus) Inhibited Metabolic Activity and Induced ROS in Selected Human HCT116 and HT-29 Colorectal Cancer Cells. | Int J Environ Res Public Health | 2022 | 36429638 | PubTator, text mining | PubMed |
| JMJD1C Regulates Megakaryopoiesis in In Vitro Models through the Actin Network. | Cells | 2022 | 36429088 | PubTator, text mining | PubMed |
| Gut Microbiota-Assisted Synthesis, Cellular Interactions and Synergistic Perspectives of Equol as a Potent Anticancer Isoflavone. | Pharmaceuticals (Basel) | 2022 | 36422548 | PubTator, text mining | PubMed |
| Ferroptosis: A new therapeutic target for bladder cancer. | Front Pharmacol | 2022 | 36408230 | PubTator, text mining | PubMed |
| Berberine prevents lethal EV71 neurological infection in newborn mice. | Front Pharmacol | 2022 | 36386168 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4778/papers?page=16